Mendelian Randomization

Overview

Mendelian randomization (MR) is a statistical method that uses genetic variants as instrumental variables to infer causal relationships between an exposure (e.g., gut microbiome composition) and an outcome (e.g., disease). Because genetic variants are randomly allocated at conception ("nature's randomized trial"), MR can distinguish causation from correlation in observational data — a critical capability for microbiome research, where most evidence is cross-sectional and confounded.

In the WikiBiome vault, MR studies provide the strongest available evidence for causal direction: does dysbiosis cause disease, or does disease cause dysbiosis? The answer is often "both" (bidirectional MR), which has profound implications for intervention timing and strategy.

Method

Core Design: Two-Sample MR

Nearly all microbiome MR studies in the vault use two-sample bidirectional MR:

  1. Exposure GWAS: Genetic variants (SNPs) associated with gut microbiome composition, primarily from the MiBioGen consortium (n=18,340; 211 taxa; 16S rRNA; multi-ethnic but predominantly European).
  2. Outcome GWAS: Disease-specific GWAS from large biobanks (UK Biobank, FinnGen, etc.).
  3. Instrumental variable analysis: SNPs associated with microbiome features serve as instruments to test whether those features causally affect disease risk.
  4. Bidirectional analysis: The reverse direction (disease→microbiome) is tested separately.

Statistical Methods

  • IVW (inverse-variance weighted): Primary analysis
  • MR-Egger: Detects and corrects for directional pleiotropy
  • Weighted median: Robust when up to 50% of instruments are invalid
  • MR-PRESSO: Outlier detection and correction
  • Cochran's Q: Heterogeneity assessment

Limitations

  • MiBioGen resolution: 16S rRNA gene, genus-level maximum. Species-level and functional (shotgun) GWAS are not yet available at comparable scale.
  • Population ancestry: Predominantly European; generalizability to other populations uncertain.
  • Weak instruments: Microbiome GWAS effect sizes are small; weak instrument bias may inflate or attenuate causal estimates.
  • Horizontal pleiotropy: SNPs may affect disease through pathways other than the microbiome.
  • Static snapshot: MR captures genetic predisposition to microbiome composition, not the dynamic, diet-responsive community.

Key Causal Findings Across Conditions

Microbiome → Disease (Forward MR)

ConditionCausal TaxaDirectionEffectSource
schizophreniaClostridia, BetaproteobacteriaRiskCausal drivers of SCZ[1]
type 1 diabetesBacteroidetesRiskOR=1.24[2]
type 1 diabetesEubacterium eligensProtectiveOR=0.64[3]
type 1 diabetesbifidobacteriumRiskOR=1.605[3]
gerdactinobacteria, lachnospiraceaeProtectiveOR=0.93[4]
[[cardiovascular-diseasecoronary-artery-disease]]odoribacterRiskOR=1.206[5]
graves diseaseintestinibacterRiskOR=1.777[6]
hashimotos thyroiditisakkermansia muciniphilaProtectiveOR=0.71[6]
colorectal cancerlachnospiraRiskOR=4.43MR studies in vault
celiac diseasebifidobacteriumRiskOR=1.401[3]

Disease → Microbiome (Reverse MR)

ConditionEffect on MicrobiomeSource
schizophreniaAkkermansia enrichment is a consequence, not cause[1]
gerdGERD causally depletes 13 taxa → bidirectional vicious cycle[4]
HypertensionDepletes alistipes, phascolarctobacterium, roseburiaMR studies in vault

Metal → Disease (MR)

ExposureConditionEffectSource
copperfibromyalgiaCausal riskOR=1.095[7]
ironfibromyalgiaCausal protectionOR=0.440[7]

Null Results (Equally Important)

  • multiple sclerosis: No replicable causal single-taxon signal despite many observational associations [3]. MR's discriminating power is demonstrated by what it doesn't find.

Paradigm-Shifting Insights

The Bifidobacterium Paradox

bifidobacterium appears protective in observational studies and is widely used as a probiotic. MR reveals it causally increases risk for T1D (OR=1.605) and celiac disease (OR=1.401) [3]. This does not invalidate probiotic use but demands strain-level and context-specific evaluation rather than blanket recommendations.

Bidirectional Vicious Cycles

GERD depletes protective taxa, and those taxa causally protect against GERD — a self-reinforcing cycle that explains disease chronicity [4]. This pattern likely applies to other chronic conditions.

Distinguishing Cause from Consequence

The most valuable MR contribution: Akkermansia enrichment in schizophrenia is a disease consequence, not a driver [1]. This kind of directional clarity prevents misguided therapeutic targeting.

Relevance to WikiBiome

MR studies serve as the causal backbone of WikiBiome's knowledge graph. While observational studies identify associations, MR provides the directional arrows:

  • For entity pages: MR evidence determines whether a taxon-disease association is causal (drives intervention strategy) or consequential (useful as biomarker only).
  • For signature pages: MR helps distinguish which signature layers are causally upstream vs. reactive downstream changes.
  • For intervention pages: Only causally implicated taxa are rational therapeutic targets; MR filters signal from noise.

Cross-References

References (14)

  1. Keer Zhou, Ancha Baranova, Hongbao Cao et al. (2024). Zhou 2024 — Gut Microbiome and Schizophrenia: Insights from Two-Sample Mendelian Randomization. Schizophrenia (Nature Partner Journal). doi:10.1038/s41537-024-00497-7
  2. Luo M, Sun M, Wang T et al. (2023). Luo 2023 — Gut microbiota and type 1 diabetes: a two-sample bidirectional Mendelian randomization study. Frontiers in Cellular and Infection Microbiology. doi:10.3389/fcimb.2023.1163898
  3. Qian Xu, Jing-Jing Ni, Bai-Xue Han et al. (2022). Xu 2022 — Causal relationship between gut microbiota and autoimmune diseases (SLE, RA, IBD, MS, T1D, CeD): two-sample Mendelian randomization. Frontiers in Immunology. doi:10.3389/fimmu.2021.746998
  4. Kui Wang, Suijian Wang, Yuhua Chen et al. (2024). Wang K 2024 — Causal Gut Microbiota-GERD Associations via Bidirectional Mendelian Randomization. Frontiers in Immunology. doi:10.3389/fimmu.2024.1327503
  5. Dan Wang, Xiaoyan Chen, Zhen Li et al. (2023). Association of the Gut Microbiota with Coronary Artery Disease and Myocardial Infarction: A Mendelian Randomization Study. Frontiers in Genetics. doi:10.3389/fgene.2023.1158293
  6. Ting Zheng, Xin Li, Hongyu Xiang (2025). Zheng 2025 — Gut-thyroid axis causality with AITD: bidirectional Mendelian randomization. Endokrynologia Polska. doi:10.5603/ep.102030
  7. Zeng et al. (2025). Zeng 2025 — Copper, Iron and Trace Elements in Fibromyalgia (Mendelian Randomization). Scientific Reports. doi:10.1038/s41598-025-86447-4
  8. Ni JJ, Xu Q, Yan SS et al. (2022). Gut Microbiota and Psychiatric Disorders: A Two-Sample Mendelian Randomization Study. Frontiers in Microbiology. doi:10.3389/fmicb.2021.737197
  9. Zuming Li, Qinghua Xia, Jieni Feng et al. (2024). Li et al 2024 — The Causal Role of Gut Microbiota in Susceptibility of Long COVID: A Mendelian Randomization Study. Frontiers in Microbiology. doi:10.3389/fmicb.2024.1404673
  10. Gang He, Yu Cao, Honghao Ma et al. (2023). He et al 2023 — Causal Effects Between Gut Microbiome and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Two-Sample Mendelian Randomization Study. Frontiers in Microbiology. doi:10.3389/fmicb.2023.1190894
  11. Mike A Nalls, Andrew B Singleton, Haydeh Payami (2021). Nalls 2021 -- Mendelian Randomization of the Gut Microbiome and Parkinson's Disease. npj Parkinson's Disease. doi:10.1038/s41531-021-00218-2
  12. Youjie Zeng, Si Cao, Heng Yang (2023). Roles of gut microbiome in epilepsy risk: a Mendelian randomization study. Frontiers in Microbiology. doi:10.3389/fmicb.2023.1115014
  13. Yuxuan Zhang, Xinyi Zhang, Delong Chen et al. (2022). Causal Associations between Gut Microbiome and Cardiovascular Disease: A Mendelian Randomization Study. Frontiers in Cardiovascular Medicine. doi:10.3389/fcvm.2022.971376
  14. Zhichen Jiang, Yiping Mou, Huiju Wang et al. (2023). Causal effect between gut microbiota and pancreatic cancer: a two-sample Mendelian randomization study. BMC Cancer. doi:10.1186/s12885-023-11493-y